Dr. Badri G. Modi, MD

Dr. Modi practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Modi's NPI, 1457613986, was assigned on June 11, 2012. Dr. Modi graduated from Yale School of Medicine in 2012. Dr. Modi holds California license A144486.

Dr. Modi's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Modi's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Dr. Modi to 1 more other site, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Modi practices. Vendor and product names are available with a free account.

Dermatology is Dr. Modi's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Modi is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Modi's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and minor injury on trunk among the conditions Dr. Modi treats.

CMS data shows 2,464 Medicare services from Dr. Modi across 19 procedure codes in 2024, for 883 Medicare patients. Medicare paid $137,070 for them.

CMS counts 883 Medicare patients who saw Dr. Modi in 2024. The largest group is 65 to 74, with 430 patients. 73% of them have high blood pressure, and 72% have high cholesterol. 28% are also on Medicaid. Their average risk score is 2.59, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Modi's median patient age at 69, with 56% women.

In 2024, Dr. Modi wrote 724 Medicare Part D claims for 294 patients. 86% of them were for generic drugs. CMS names the drug for 604 of them, across 18 drugs with 11 or more claims each, at $448,637 in total drug cost. In 2023, CMS named 405 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Modi for performance year 2024, reported as part of a group. Dr. Modi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Modi as offering telehealth. CMS counts 321 procedures of removal of skin lesions by Dr. Modi, more than 83% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 24 papers to Dr. Modi, published from 2011 to 2025. 2025 was the busiest year, with 4. The most frequent topics are Graft vs Host Disease, Hematopoietic Stem Cell Transplantation and Skin Neoplasms. Dr. Modi has published most often in Expert Rev Clin Immunol. Dr. Modi's most frequent co-authors are Ryotaro Nakamura, MD, Amandeep Salhotra, MD and Haris Ali, MD.

CMS Open Payments shows 521 general payments to Dr. Modi from 15 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 70% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $259,376. It also lists 51 research payments totaling $8,096 from 2018 to 2025, naming 1 clinical trial.

Dr. Modi graduated from Yale School of Medicine in 2012.

Dr. Modi is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.